EvanRGoldfischerMD

Urology • Poughkeepsie, NY

Director of the Research Department at Premier Medical Group

Join to view full profile

Dr. Goldfischer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Goldfischer's full profile

Already have an account?

Office
1 Columbia Street
Ste 390
Poughkeepsie, NY 12601
Phone+1 845-437-5000

Fax+1 845-452-2406
Is this information wrong?

Education & Training

University of ChicagoResidency, Urology, 1993 - 1997
University of ChicagoInternship, Transitional Year, 1992 - 1993
Weill Cornell MedicineClass of 1992

Certifications & Licensure

NY State Medical License 1996 - 2026
NH State Medical License 2009 - 2025
NJ State Medical License 2021 - 2025
IL State Medical License 1992 - 1999
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011-2013
Fellow (FACS) American College of Surgeons

Clinical Trials

Efficacy Study of VA106483 in Males With Nocturia. Start of enrollment: 2009 Dec 01
Completed
Phase 2
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
Terminated
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
Terminated
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Telemedicine Utilization in the COVID-19 Era: Patterns of Care in Community Urology Practice.
Zhang, S., Albala, D., Bart, A., Goldfischer, E., Dowling, R.> ;Urology Practice. 2024 Mar 7
Reply by Authors.
Robert A Dowling, Qingxia Chen, Evan Goldfischer, David M Albala> ;Urology Practice. 2023 Jul 1
Surgical Stone Treatment: Patterns May Predict Performance on Episode-based Cost Measure in the Quality Payment Program.
Robert A Dowling, Qingxia Chen, Evan Goldfischer, David M Albala> ;Urology Practice. 2023 Jul 1
13 citations
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Chamie, K., Chang, S., Kramolowsky, E., Gonzalgo, M., Agarwal, P., Bassett, J., Bjurlin, M., Cher, M., Clark, W., Cowan, B., David, R., Goldfischer, E., Guru, K., Jalk...> ;NEJM Evidence. 2023 Jan 1
2 citations
An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implant...
Dean Elterman, Mark N Alshak, Susana Martinez Diaz, Neal Shore, Marc Gittleman, Jay Motola, Sheldon Pike, Craig Hermann, William Terens, Alfred Kohan, Ricardo Gonzalez...> ;Journal of Endourology. 2023 Jan 1
Urinary Analysis ofandGene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
Yair Lotan, Jay D Raman, Badrinath Konety, Siamak Daneshmand, Florian Schroeck, Shahrokh F Shariat, Peter Black, Michel de Lange, Scott Asroff, Evan Goldfischer, Mitch...> ;The Journal of Urology. 2023 Apr 1
31 citations
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, ...
Bilal Chughtai, Dean Elterman, Neal D. Shore, Marc Gittleman, Jay Motola, Sheldon Pike, Craig Hermann, William Terrens, Alfred Kohan, Ricardo R. Gonzalez, Aaron E. Kat...> ;Urology. 2021 Jul 1
Clinical Research 2021.
Evan R. Goldfischer> ;The Urologic Clinics of North America. 2021 Mar 11
4 citations
Preserving Independent Urology: LUGPA's First Decade.
Neal D. Shore, Deepak A. Kapoor, Evan R. Goldfischer, David C Chaikin, Earl L Walz, R. Jonathan Henderson, Richard G. Harris, Robert D Asinof, Gary M Kirsh> ;Reviews in Urology. 2019 Jan 1
35 citations
A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
Scott E. Eggener, Lawrence Karsh, Tim Richardson, Alan W. Shindel, Ruixiao Lu, Steven Rosenberg, Evan R. Goldfischer, Howard J. Korman, John D. Bennett, Jay R. Newmark...> ;Urology. 2019 Apr 1
88 citations
Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
Yair Lotan, Paul OʼSullivan, Jay D. Raman, Sharokh F. Shariat, Laimonis Kavalieris, Chris Frampton, Parry Guilford, Carthika Luxmanan, James Suttie, Henry Crist, Dougl...> ;Urologic Oncology. 2017 Aug 1
33 citations
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort
Gregg Eure, Robert Given, Ruixiao Lu, Alan W. Shindel, Megan P. Rothney, Richard Glowacki, Jonathan Henderson, Tim Richardson, Evan R. Goldfischer, Phillip G. Febbo, B...> ;Urology. 2017 Apr 25
10 citations
Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer
Jürgen Breul, Eija Lundstrom, Daniela Purcea, Werner P. Venetz, Patrick Cabri, Pascale Dutailly, Evan R. Goldfischer> ;Advances in Therapy. 2017 Feb 1
6 citations
Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or varden...
Edward Kim, Allen D. Seftel, Evan R. Goldfischer, Simin K. Baygani, Patrick R. Burns> ;Current Medical Research and Opinion. 2015 Feb 18
18 citations
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
Evan R. Goldfischer, Peter K. Sand, Heather Thomas, Jill Peters-Gee> ;Neurourology and Urodynamics. 2015 Jan 1
8 citations
Impact of Low Testosterone on Response to Treatment With Tadalafil 5 mg Once Daily for Erectile Dysfunction
Evan R. Goldfischer, Edward D. Kim, Allen D. Seftel, Simin K. Baygani, Patrick R. Burns> ;Urology. 2014 Jun 1
39 citations
Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 M...
Hartmut Porst, Matthias Oelke, Evan R. Goldfischer, David A. Cox, Steven Watts, Debashish Dey, Lars Viktrup> ;Urology. 2013 Sep 1
19 citations
A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
Edward D. Kim, Allen D. Seftel, Evan R. Goldfischer, Xiao Ni, Patrick R. Burns> ;The Journal of Sexual Medicine. 2014 Mar 1
21 citations
Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder.
Anita H. Clayton, Evan R. Goldfischer, Irwin Goldstein, Leonard R. Derogatis, Rossella E. Nappi, Diane J. Lewis-D'Agostino, Toshio Kimura, Antoine Hebert, Robert Pyke> ;Journal of Sex & Marital Therapy. 2013 Jan 1
23 citations
Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of ...
Evan R. Goldfischer, John J. Kowalczyk, William R. Clark, Erin Brady, Michael A. Shane, Nancy Dgetluck, Suzanne Klise> ;Urology. 2012 Apr 1
44 citations
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): Results from a randomized withdrawal trial
Evan R. Goldfischer, Jeffery Breaux, Molly Katz, Joel D. Kaufman, William B. Smith, Toshio Kimura, Michael Sand, R.b. Pyke> ;The Journal of Sexual Medicine. 2011 Nov 1
20 citations
Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study.
Jean-Jacques Wyndaele, Evan R. Goldfischer, Jon D. Morrow, Jason Gong, Li-Jung Tseng, Myung-Soo Choo> ;BJU International. 2011 Feb 1
100 citations
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study.
Craig F. Donatucci, Gerald B. Brock, Evan R. Goldfischer, Peter Pommerville, Albert Elion-Mboussa, Jay D. Kissel, Lars Viktrup> ;BJU International. 2011 Apr 1
13 citations
Onset of Efficacy of Tadalafil Once Daily in Men With Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Trial
Allen D. Seftel, Evan R. Goldfischer, Edward D. Kim, Eugene Dula, Haoyue Zeigler, Patrick R. Burns> ;The Journal of Urology. 2011 Jan 1
15 citations
Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes
Steven A. Kaplan, Evan R Goldfischer, William D. Steers, Marc Gittelman, Masakazu Andoh, Sergio Forero-Schwanhaeuser> ;The Aging Male. 2010 Apr 29
Join now to see all

Press Mentions

I'm a Urologist. 7 Signs the Way You Pee May Be Hurting Your HealthApril 11th, 2023
How PE Investment Could Affect Independent Physicians: 3 Insights from Dr. Evan GoldfischerDecember 3rd, 2019
Even Urologists Get Kidney Stones – Medical School Alumnus Passes on KnowledgeSeptember 30th, 2018
Join now to see all